Also, receiver operating characteristics (ROC) analysis was used to evaluate the predictive value of the SCF plasma level for discrimination between the GBM patients, healthy controls (Figure 1B), and patients with nonglial tumors (Figure 1C). Here, KITLG is linked to glioblastoma.